Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Amipak
2. Amipaque
1. 31112-62-6
2. 3-acetamido-2,4,6-triiodo-5-(n-methylacetamido)-n-((3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-3-yl)benzamide
3. 55134-11-7
4. 2-[({3-(acetylamino)-5-[acetyl(methyl)amino]-2,4,6-triiodophenyl}carbonyl)amino]-2-deoxy-d-glucopyranose
5. Ncgc00016805-01
6. Amipaque (tn)
7. Cas-31112-62-6
8. Prestwick3_000463
9. Dsstox_cid_3310
10. Dsstox_rid_76969
11. Dsstox_gsid_23310
12. Schembl24382
13. Bspbio_000566
14. Mls002153823
15. Metrizamide (jan/usan/inn)
16. Bpbio1_000624
17. Chembl462394
18. Dtxsid1023310
19. Schembl16984723
20. Chebi:31841
21. Hms2096m08
22. Hms2230m07
23. Hms3713m08
24. Tox21_110619
25. Stl564457
26. Akos015965061
27. Ccg-220463
28. Cs-w000133
29. Hy-w000133
30. Ncgc00179520-01
31. Ncgc00179520-04
32. 3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
33. Smr001233191
34. Ab00513843
35. D01311
36. D77558
37. Ab00513843_06
38. 112m626
39. Sr-01000841219
40. J-018245
41. Q6824399
42. Sr-01000841219-2
43. 3-acetamido-2,4,6-triiodo-5-(n-methylacetamido)-n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
| Molecular Weight | 789.1 g/mol |
|---|---|
| Molecular Formula | C18H22I3N3O8 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 788.8541 g/mol |
| Monoisotopic Mass | 788.8541 g/mol |
| Topological Polar Surface Area | 169 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 719 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media
V08AB01 - Metrizamide
ABOUT THIS PAGE
53
PharmaCompass offers a list of Metrizamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metrizamide manufacturer or Metrizamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metrizamide manufacturer or Metrizamide supplier.
PharmaCompass also assists you with knowing the Metrizamide API Price utilized in the formulation of products. Metrizamide API Price is not always fixed or binding as the Metrizamide Price is obtained through a variety of data sources. The Metrizamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metrizamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metrizamide, including repackagers and relabelers. The FDA regulates Metrizamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metrizamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Metrizamide supplier is an individual or a company that provides Metrizamide active pharmaceutical ingredient (API) or Metrizamide finished formulations upon request. The Metrizamide suppliers may include Metrizamide API manufacturers, exporters, distributors and traders.
Metrizamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metrizamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metrizamide GMP manufacturer or Metrizamide GMP API supplier for your needs.
A Metrizamide CoA (Certificate of Analysis) is a formal document that attests to Metrizamide's compliance with Metrizamide specifications and serves as a tool for batch-level quality control.
Metrizamide CoA mostly includes findings from lab analyses of a specific batch. For each Metrizamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metrizamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Metrizamide EP), Metrizamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metrizamide USP).
